Nexium controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile1 entries
2003
Patent and market-exclusivity scrutiny
Nexium attracted public and legal scrutiny over AstraZeneca’s efforts to protect and extend the commercial life of esomeprazole as omeprazole faced generic competition. The controversy centered on pharmaceutical lifecycle management and allegations that the company’s strategy could delay or restrict generic competition.